Here's a list of key deals reported across sectors this week: Entities tied to Makarora Management, along with Ares Alternative Credit funds, have agreed to acquire all outstanding shares of Plymouth Industrial REIT (NYSE:PLYM) in all all-cash

Eli Lilly (LLY) is strengthening its presence … by January 22, 2026. Is Eli Lilly a Buy, Sell, or Hold … . At $909.44, the average Eli Lilly stock price target implies a …

… (CDSCO) has accepted drug major Eli Lilly's request to withdraw …

… Ropes & Gray LLP-advised Eli Lilly said Friday it has agreed …

… that the company will sell Eli Lilly’s weight-loss drug Mounjaro … is significant, as it allows Eli Lilly’s weight-loss drug to … Cipla Inks Deal To Sell Eli Lilly’s Weight-Loss Drug; Sena …

… new brand name—Yurpeak. Eli Lilly has partnered with Cipla … has. Wider Distribution Network Eli Lilly's distribution network … and general manager at Eli Lilly India, said in the … Push With Commercial Flexibility Eli Lilly may have maintained price …

Eli Lilly and Co. (NYSE:LLY) on … more individualized treatment. Also Read: Eli Lilly’s Oral Weight Loss Drug … 12 weeks (Q12W) is underway. Eli Lilly and its partner, Incyte Corporation …

Eli Lilly announces that its treatment EBGLYSS ( … while maintaining disease control." Eli Lilly has submitted these data to …

Eli Lilly announces the signing of a … the treatment of AMD." Eli Lilly will provide up to $65 …

Cipla-Eli Lilly partner to distribute Tirzepatide … striking a deal with Eli Lilly’s Indian unit to … diabetes management drug. Cipla-Eli Lilly Partnership To Distribute Tirzepatide Cipla … has partnered with Eli Lilly and Company (India) to …